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To date, efforts to switch the cofactor speciﬁcity of oxidoreductases
from nicotinamide adenine dinucleotide phosphate (NADPH) to ni-
cotinamide adenine dinucleotide (NADH) have been made on a case-
by-case basis with varying degrees of success. Here we present a
straightforward recipe for altering the cofactor speciﬁcity of a class of
NADPH-dependent oxidoreductases, the ketol-acid reductoisomerases
(KARIs). Combining previous results for an engineered NADH-de-
pendent variant of Escherichia coli KARI with available KARI crystal
structures and a comprehensive KARI-sequence alignment, we identi-
ﬁed key cofactor speciﬁcity determinants and used this information to
construct ﬁve KARIs with reversed cofactor preference. Additional di-
rected evolution generated two enzymes having NADH-dependent
catalytic efﬁciencies that are greater than thewild-type enzymeswith
NADPH. High-resolution structures of a wild-type/variant pair reveal
the molecular basis of the cofactor switch.
branched-chain amino acid pathway | cofactor imbalance
Ketol-acid reductoisomerases (KARI; EC 1.1.1.86) are a familyof nicotinamide adenine dinucleotide phosphate (NADPH)-
dependent oxidoreductases that catalyze an alkyl-migration fol-
lowed by a ketol-acid reduction of (S)-2-acetolactate (S2AL) and
2-aceto-2-hydroxybutyrate to yield (R)-2,3-dihydroxy-isovalerate
and (R)-2,3-dihydroxy-3-methylvalerate, respectively (1), which are
essential intermediates in the biosynthesis of branched-chain
amino acids (BCAAs) (2, 3). The demand for these essential amino
acids, used in the preparation of animal feed, human dietary sup-
plements, and pharmaceuticals, is currently estimated to exceed
1,500 tons per year (4). In addition, the BCAA pathway has been
engineered to produce ﬁne chemicals and biofuels, including
1-butanol and isobutanol (5, 6). Under the anaerobic conditions
preferred for large-scale fermentations, biosynthesis of BCAAs and
other products that use this pathway is limited by the pathway’s
cofactor imbalance and reduced cellular production of NADPH
(7, 8). One approach to overcoming the cofactor imbalance is to
engineer KARI to use NADH generated in glycolysis, thereby
enabling anaerobic production of BCAA pathway products (7, 8).
Efforts to switch the cofactor speciﬁcity of oxidoreductases from
NADPH to NADH have been made with varying degrees of suc-
cess (8–17). The three reports of cofactor-switched KARIs (7, 8,
15) from two different organisms show few commonalities in terms
of residues targeted for engineering. A general recipe for switching
KARI cofactor speciﬁcity would allow metabolic engineers to take
advantage of the natural sequence diversity of the KARI family,
with concomitant diversity in properties such as expression level,
pH tolerance, or thermal stability. By combining a systematic
analysis of all reviewed and manually annotated [SwissProt (18)]
KARIs, information from our previous work on switching the
cofactor speciﬁcity of the Escherichia coli KARI (7), and available
KARI structures, we have identiﬁed a subset of residues in the
β2αB-loop of the Rossmann fold that distinguish NADPH and
NADH. Here we provide a nuanced guide to engineering KARI
cofactor speciﬁcity and apply it to three different KARIs that are
representatives of the three canonical KARI β2αB-loop lengths.
We also demonstrate that wild-type-like activity using this co-
factor, required for industrial applications, can be achieved by
directed evolution once cofactor preference has been reversed.
High-resolution structures of a wild-type KARI and its cofactor-
switched variant with the respective cofactors bound demonstrate
how the switch was achieved.
Results and Discussion
In previous work, we described E. coli KARI variant Ec_IlvC6E6
with four mutations (Ala71Ser, Arg76Asp, Ser78Asp, and
Gln110Val) that resulted in a 54,000-fold reversal in cofactor
speciﬁcity for NADH over NADPH (7). This variant was also
highly active when using NADH (85% of wild-type activity using
NADPH). Structural analysis of wild-type Ec_IlvC with and
without bound cofactor [PDB code 1YRL (19) and PDB code
3ULK (20)] showed that three of the four Ec_IlvC6E6 mutations
(Ala71Ser, Arg76Asp, and Ser78Asp) are in a loop connecting the
β2 sheet and the αB helix of the Rossmann fold (21), hereafter
referred to as the β2αB loop. Arg76 and Ser78 are in direct contact
with the 2′-phosphate of NADPH. The existence of β2αB loops of
varying lengths obscured sequence patterns of NADPH speciﬁcity
in KARI multiple sequence alignments (1, 8, 15, 22). To ﬁnd the
commonalities among KARI β2αB loops, we systematically ana-
lyzed the loop regions of the entire enzyme class (E.C. 1.1.1.86).
We generated a multiple sequence alignment of all 643 SwissProt
(18) annotated and reviewed KARI sequences (analysis in Table
S1) and used structural data to identify and reﬁne the β2αB loop
region in the alignment. An N-terminal excerpt (Fig. 1A) of the
alignment of a few representative KARIs shows the well-known,
conserved GxGxxG motif (23) and the loop region 18 amino
acids downstream, which is diverse in both length and amino
acid sequence.
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On the basis of the sequence alignment alone, the diversity of this
region might seem to argue against a conserved function of loop
residues (Fig. 1A). However, analysis of the 643 KARI sequences
shows three different loop lengths: six (14%), seven (68%), and 12
residues (18%) (Fig. 1B). On subalignment of KARIs according to
loop length, common conservation patterns emerge: a positively
charged residue (73% Arg and 9% Lys) usually appears at the N-
terminal end of the β2αB loop, and small, polar residues such as
serine (85%) or threonine (11%) predominate at the C-terminal
end. The last two residues in the six-residue loops are conserved
(Lys/Arg and Ser), and the last three residues follow the pattern SxS
in seven-residue and RxS in 12-residue loops.
Comparison of the β2αB loop segment of all available KARI
structures [seven structures from four different organisms (19, 20,
24–27)] provides an explanation for the trends found in the se-
quence alignment. Three of the seven structures have NADPH
cocrystallized, and in all those cases, the small polar C-terminal
residues interact with the NADPH 2′-phosphate. The conserved
N-terminal Arg is homologous to Arg68 in Ec_IlvC6E6, which has
recently been shown to form a cation–pi interaction with the
NADPH adenine ring (20) and likely plays a dual role in binding
the nucleobase, as well as the 2′-phosphate. On the basis of these
ﬁndings, we postulate that the β2αB loop is a major determinant of
NADPH cofactor speciﬁcity in wild-type KARIs. This analysis of
the β2αB loop provides the basis for transferring previously re-
ported cofactor-switching mutations in Ec_IlvC6E6 to corresponding
residues in KARIs that have similar 12-residue loops, as well as
KARIs with six- and seven-residue loops.
Transfer of a 12-Residue Cofactor Switch Solution to Seven- and Six-
Residue β2αB Loops: Se_ KARI from Slackia exigua and Ll_KARI from
Lactococcus lactis. We examined the transferability of mutations
previously reported for Ec_IlvC6E6, which has a 12-residue loop, to
KARIs with shorter loops using Se_KARI from S. exigua (seven
residues) and Ll_KARI from L. lactis (six residues) (Fig. 1). On
inspection of the sequence alignment in Fig. 1A, we identiﬁed
residues Ser61 and Ser63 of Se_KARI as corresponding to resi-
dues Arg76 and Ser78 in Ec_IlvC (Arg76Asp and Ser78Asp in
Ec_IlvC6E6). Ec_IlvC mutation Ala71Ser had no match in the
Se_KARI amino acid sequence because of the latter enzyme’s
shorter β2αB loop. Grafting both aspartates from Ec_IlvC6E6 into
Se_KARI resulted in variant Se_KARIDD (Ser61Asp and Ser63-
Asp) and a 7,800-fold reversal of cofactor speciﬁcity fromNADPH
to NADH. Se_KARIDD (Table 1) had an eightfold decreased kcat
with NADPH (from 0.8 to 0.1 s−1), whereas the kcat with NADH
increased from 0.4 to 1.0 s−1. The mutations increased the KM for
NADPH 880-fold, but only 2.5-fold for NADH. Overall, the cata-
lytic efﬁciency for NADH remained the same, whereas catalytic
efﬁciency for NADPH was reduced 7,300-fold to 0.11 mM−1s−1
(Table 1). That switching Se_KARI cofactor speciﬁcity was ach-
ieved with only two mutations suggests that KARIs with seven-
residue and 12-residue β2αB loops share similar cofactor speci-
ﬁcity determinants involving interactions with small, polar residues
at the end of the β2αB loop.
Ll_KARI is a representative of the 14% of the 643 KARI
sequences with a six-residue β2αB loop.Whereas in 12- and seven-
residue β2αB-loop KARIs the antepenultimate and ultimate res-
idues are highly conserved, in six-loop KARIs the ultimate con-
served serine is usually preceded by a positively charged residue at
the penultimate position. We hypothesized that residues Lys52
and Ser53 of Ll_KARI were equivalent in function to residues
Arg76 and Ser78 in Ec_IlvC. Ll_KARIDD variant with mutations
Lys52Asp and Ser53Asp, however, expressed at an extremely low
level and exhibited no measurable activity with either cofactor,
which could be a result of the destabilizing effects of the two ad-
jacentAsp residues. Similar results were obtained with Ll_KARIED.
These two Asp mutations are separated by an additional residue in
KARIs with the longer β2αB loops. The failed transfer of E. coli
cofactor switch mutations to Ll_KARI suggests that KARIs with
six-residue loops require a modiﬁed approach.
To develop a recipe for switching cofactor speciﬁcity in KARIs


















Fig. 1. (A) Excerpt of amultiple sequence alignment
of L. lactis KARI (Ll_KARI, Q02138), A. acidocaldarius
KARI (Aa_KARI, C8WR67), S. exigua KARI (Se_KARI,
D0WGK0), M. aeolicus KARI (Ma_KARI, A6UW80),
Shewanella sp. KARI (Sh_KARI, A0KS29), E. coli KARI
(Ec_IlvC, P05793), and Ec_IlvC6E6. The GxGxxGmotif is
highlighted in bold and boxed. The β2αB loop is
boxed. Mutations of variant Ec_IlvC6E6 are shown
in bold. (B) Subalignments according to β2αB-loop
length uncover three different conservation patterns
we suggest are important for 2′-phosphate interac-
tion. Colors in the sequence logo refer to hydro-
phobic (black), positively charged (blue), negatively
charged (red), and polar (green) residues.








mutagenesis libraries at each of the six loop residues in Ll_KARI
(Val48, Arg49, His50, Gly51, Lys52, and Ser53), expecting that the
β2αB loop also is key to speciﬁcity in this KARI family. On
screening for activity with both cofactors, we found no single mu-
tation that resulted in an NADH-preferring variant (rate of
NADH consumption > rate of NADPH consumption at saturating
substrate conditions). Mutations were identiﬁed at Arg49 (Pro) and
Val48 (Leu) that increased activity with both cofactors. Saturation
mutagenesis at His50, Gly51, Lys52, and Ser53 did not yield variants
with improved NADH activity. Convinced that NADPH speciﬁcity
in KARIs with a six-residue β2αB loop is conveyed in a similar
manner as in KARIs with seven- and 12-residue loops, we built
a dual-site library by saturation mutagenesis at Lys52 and Ser53
while also incorporating the Val48Leu and Arg49Pro mutations.
Screening this library to ∼80% coverage, we identiﬁed two variants,
Ll_KARILPLD (mutations Val48Leu, Arg49Pro, Lys52Leu, and
Ser53Asp) and Ll_KARILPED (mutations Val48Leu, Arg49Pro,
Lys52Glu, and Ser53Asp), with 46-fold and 54-fold speciﬁcity for
NADH over NADPH (Table 1), representing speciﬁcity shifts of
6,600 (Ll_KARILPLD) and 7,700 (Ll_KARILPED).
These cofactor-switched KARIs with six-residue loops contained
mutations to four of the six loop residues, suggesting that KARIs
with six-residue loops are slightly more difﬁcult templates for en-
gineering the cofactor switch. Although mutation of the conserved
arginine at the beginning of the β2αB loop was not required to
switch cofactor speciﬁcity in seven- and 12-loop KARIs, variant
Ll_KARILRLD with Pro reverted to Arg showed that the Arg
contributes to NADPH cofactor preference in six-residue loop
KARIs. Reversion of Pro49 to Arg not only reduced the cofactor
KM values (twofold for NADHand threefold for NADPH) (Table
S2) but also decreased the kcat on NADH (fourfold), thereby
reducing the 46-fold preference for NADH over NADPH to
only sixfold. Reversion of Leu48 to Val (Ll_KARIVPLD)
lowered the catalytic efﬁciency on NADH threefold (because
of a reduction in kcat), whereas the NADPH KM was reduced
twofold. Although polar residues at the C-terminal end of the
loop and charged residues at the N-terminal end of the loop con-
tinue to support NADPH speciﬁcity, removing the polar residues
at the C-terminal end of the loop might not be sufﬁcient to
switch the speciﬁcity of six-residue loop KARIs in favor of
NADH. In the shorter six-residue loop KARIs, the N-terminal,
positively charged Arg residue appears to form stronger inter-
actions with the 2′-phosphate than in the seven- and 12-residue loop
KARIs, possibly because of its closer packing and proximity to
the cofactor. A six-amino acid loop KARI structure with co-
factor would help elucidate the detailed mechanism.
Recovering Catalytic Activity of Cofactor-Switched Enzymes. Shifting
cofactor preference often decreased the overall activity (i.e., cat-
alytic efﬁciency using NADH) relative to the wild-type enzyme
using NADPH, which is also true for other cofactor-switched
enzymes (9–11, 13, 15). To demonstrate that the activity of the
cofactor-switched variants can be improved to match or even
surpass the wild-type enzyme, we randomly mutated Se_KARIDD,
Ll_KARILPLD, and Ec_IlvC6E6 and screened for higher total
activity in cell lysate. For Se_KARI, we identiﬁed variant
Se_KARIDDV with mutation Ile95Val. Interestingly, this mutation
corresponds to Gln110Val, which was previously found in
Ec_IlvC6E6, and is speculated to confer general activation by op-
timizing cofactor orientation for catalysis. With Ll_KARI, we
isolated variant Ll_KARI2G6, which contained three new
mutations: Glu59Lys, Thr182Ser, and Glu320Lys. These muta-
tions effectively restored the enzyme to wild-type levels of ac-
tivity; the catalytic efﬁciency of Ll_KARI2G6 with NADH was
Table 1. Biochemical properties of Ec_IlvC (12 residues), Sh_KARI (12 residues), Se_KARI (seven residues), Ma_KARI (seven residues),







NADH NADPH NADH NADPH NADH NADPH
Ec_IlvC (7) — 1,075 41 0.3 3.6 0.3 88
Ec_IlvC6E6 (7) Ala71Ser, Arg76Asp, Ser78Asp, Gln110Val 30 650 2.3 0.2 74 0.4
Ec_IlvCP2D1-A1 Ala71Ser, Arg76Asp, Ser78Asp, Gln110Val,
Asp146Gly, Gly185Arg, Lys433Glu
26 >1,400 4.3 0.54 165 0.4
Sh_KARI — 415 1.0 1.1 4.5 2.6 4,500
Sh_KARIDD Arg76Asp, Ser78Asp 90 >1,000 1.30 0.10 14 0.17
Sh_KARI6E6 Ala71Ser, Arg76Asp, Ser78Asp, Gln110Val 75 600 2.40 0.30 32 0.5
Se_KARI — 45 1.0 0.41 0.8 9 800
Se_KARIDD Ser61Asp, Ser63Asp 113 880 0.97 0.10 9 0.11
Se_KARIDDV Ser61Asp, Ser63Asp, Ile95Val 47 >1,000* 1.01 0.25 22 0.25
*Ma_KARI — 59 17.3 0.3 0.7 4.6 43
*Ma_KARIDD Gly50Asp, Ser52Asp 26 80 0.15 0.004 6.2 0.05
Ll_KARI — 285 13 0.10 0.8 0.43 65
Ll_KARILPLD Val48Leu, Arg49Pro, Lys52Leu, Ser53Asp 108 1,000 0.40 0.08 3.7 0.08
Ll_KARILPED Val48Leu, Arg49Pro, Lys52Glu, Ser53Asp 128 1,180 0.35 0.06 2.7 0.05
Ll_KARI2G6 Val48Leu, Arg49Pro, Lys52Leu, Ser53Asp, Glu59Lys,
Thr182Ser, Glu320Lys
15 749 1.07 0.35 71 0.47
*Aa_KARI — 28 18 0.26 0.66 9 37
*Aa_KARIPLD Arg48Pro, Ser51Leu, Ser52Asp 43 >1,000 0.032 0.013 0.7 <0.013
*Aa_KARIPLDA Arg48Pro, Ser51Leu, Ser52Asp, Arg84Ala 27 >1,000 0.03 0.01 1.1 <0.01
All enzymes were his6-tagged and puriﬁed before characterization. The mutations are given relative to each wild-type sequence. Each value represents the
average of three independent measurements. Enzyme activities were determined in 100 mM potassium phosphate at pH 7 with 1 mM DTT, 200 μM NADPH or
NADH, 10 mM S2AL, and 10 mM MgCl2. Concentrations of the puriﬁed enzymes were determined using the Bradford assay. The Michaelis–Menten constants
for the cofactors were measured with appropriate dilutions of NADPH and NADH in the presence of saturating concentrations of substrate S2AL. Mutations
located within the β2αB-loop are highlighted in bold. For errors, please refer to Table S2.
*Ma_KARI, Aa_KARI, and their variants show cooperative behavior, and their kinetics follow the Hill equation instead of the Michaelis–Menten equation:
afﬁnity is described as KH and catalytic efﬁciency as kcat/KH to compare them with the other KARIs. Hill coefﬁcients are provided in Table S2.
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∼10% higher than wild-type Ll_KARI with NADPH (71 vs. 65
mM−1s−1). The Ec_IlvC6E6 random mutant library yielded
variant Ec_IlvCP2D1-A1, also with three additional mutations
(Asp146Gly, Gly185Arg, and Lys433Glu) and an approxi-
mately twofold greater catalytic efﬁciency on NADH than the
wild-type on NADPH (Table 1). The random mutations in
Ec_ILvCP2D1-A1 and Ll_KARI2G6 are surface mutations, and
their effects are difﬁcult to rationalize. These three examples
demonstrate that the activity of a cofactor-switched enzyme can
be improved, even to levels that exceed wild-type activity, and that
activating mutations can be found outside of the speciﬁcity-
determining β2αB loop.
Cofactor Switch Guide for the KARI Enzyme Family. We propose the
following guide for switching KARI cofactor speciﬁcity, which
does not require a priori knowledge of the KARI structure (Fig.
2). The ﬁrst step is the identiﬁcation of the β2αB loop and its
length via sequence alignment against the KARIs reported in this
work or a multiple sequence alignment of all KARIs. If the target
KARI has a 12- or seven-residue loop, replacement of the last and
third-to-last residue of the loop with aspartates is likely to achieve
a switch in cofactor speciﬁcity. In the case of the six-residue loop,
a modiﬁed approach is required. The last polar loop residue
should be mutated to aspartate, and the conserved charged resi-
due near the N-terminus of the loop should be mutated to Pro.
Simultaneously, the penultimate loop residue should be targeted
for site-saturation mutagenesis. This approach led to reversed
cofactor preference in both test cases. Last, to achieve wild-type-
like activity for NADH, additional mutations that ﬁne-tune
cofactor orientation, as exempliﬁed by Gln110Val or Ile95Val,
may be introduced, and further enhancement of activity can be
achieved by random mutagenesis and screening.
Application of the Cofactor Switch Guide. We tested the proposed
protocol on three additional KARIs representing the β2αB-loop
lengths (12, seven, and six residues) and composition. With the
addition of these three KARIs, we covered the different phylo-
genetic subbranches of the KARI enzyme family. Representative
of 12-residue β2αB-loop KARIs was Sh_KARI from Shewanella
Fig. 2. Cofactor switch guide for the KARI enzyme family. Steps include (1)
identiﬁcation of the loop, (2) determination of β2αB-loop length and mu-
tation based on loop length, and (3) improvement of overall activity on
NADH via random mutagenesis.
Fig. 3. Catalytic efﬁciency NADH/catalytic efﬁciency
NADPH, on log scale, for six wild-type KARIs (light
gray) and their cofactor-switched variants (dark gray).








sp.Methanococcus aeolicusMa_KARI (28) exempliﬁes the seven-
residue type, and Aa_KARI from Alicyclobacillus acidocaldarius
has a six-residue loop (Table 1). We used this last enzyme to test
the transferability of the Q110/I95 position by making and
screening a site-saturation library at position Arg84.
By introducing a customized set of two to four mutations based
on the guide in Fig. 2, we obtained variants with the desired co-
factor speciﬁcity for KARI family members sharing as little as 20%
sequence identity (Table S3). Low catalytic efﬁciency in cofactor-
switched variants can be remedied by directed evolution, as
demonstrated for Ec_IlvCP2D1-A1 and Ll_KARI2G6. Mutations
(Ala or Val) at positions corresponding to Ec_IlvC’s Q110 im-
proved activity in three different KARIs. Overall, catalytic efﬁ-
ciency ratios (NADH/NADPH) of more than 400-fold (Fig. 3)
with catalytic efﬁciencies up to 188%of those of the corresponding
wild-type enzymes using NADPHwere achieved, corresponding to
shifts in cofactor speciﬁcity of 200–200,000-fold.
Molecular Determinants of Cofactor Speciﬁcity in KARIs. We solved
the crystal structures of Se_KARI wild-type enzyme (1.39 Å, PDB
4KQW) and variant Se_KARIDDV (1.8 Å, PDB 4KQX) with their
respective cofactors. The crystallographic parameters are sum-
marized in Table S4. These structures conﬁrm that only the β2αB
loop is involved in interactions with the respective 2′-moiety,
and thus is responsible for speciﬁcity. In the wild-type structure,
three residues form direct interactions with the 2′-phosphate of
NADPH: Arg58, Ser61, and Ser63. The structures support the
suggested dual role of Arg58: the positively charged guanidinium
moiety is 3.5 Å from the adenine moiety of the cofactor in both
structures, forming cation–pi stacking interactions (29), as repor-
ted for E. coli KARI (20). At the same time, this side chain could
form a salt bridge to the negatively charged 2′-phosphate of
NADPH (possibly also involving the oxygen of the phosphoester
bond) and a hydrogen bond to the 2′-OH in NADH.
The residues that were mutated to alter cofactor preference,
Ser61 and Ser63, are in a position to hydrogen bond directly to at
least a single oxygen atom of the phosphate. The high-resolution
structures revealed water molecules surrounding the 2′-phosphate
group, enabling additional, indirect interactions with the side chains
of Arg58, Ser61, and Ser63 (Fig. 4). The side chain of Ser62 sta-
bilizes this network of water molecules, as does the Arg58 backbone.
In the mutant structure, the β2αB loop is moved slightly closer to-
ward the cofactor. Mutations Ser61Asp and Ser63Asp would in-
terrupt the serine hydrogen bonding interactions and also result in
electrostatic repulsion to the 2′-phosphate of NADPH. The carboxyl
groups of the two aspartates compensate for the missing 2′-phos-
phate by ﬁlling the pocket and substituting its negative charge. In
addition, the β carboxyl group of Ser61Asp is at an ideal distance for
hydrogen bonding to the 2′-hydroxyl group of NADH. As in the
wild-type structure, water molecules link the 2′-hydroxyl moiety of
the ribose sugar with Arg58 and Asp63 by hydrogen bonds.
Whereas these mutations shifted the KARI cofactor preference,
improved catalytic activity was achieved by substituting an addi-
tional residue that is not part of the loop, Ile95, with Val. This
mutation retained the hydrophobic nature while allowing the ad-
enine moiety to shift about 1 Å toward the side chain of residue 95.
This compensates exactly the distance the β2αB loop is ﬂipped
inward in the mutant structure at position Arg58 and preserves the
cation–pi stacking of the adenine moiety and the side chain of
Arg58, which is in the same rotamer conformation in the wild-type
and in the cofactor-switched mutant. We propose that this move-
ment compensates for the slightly different conformations of
NADPH and NADH and readjusts the catalytically active nico-
tinamidemoiety of NADH to take on amore favorable position for
electron transfer. A similar activating mechanism is speculated for
Ec_IlvC6E6’s Gln110Val mutation (7). All other interactions of
Se_KARIDDV with the cofactor, for instance, involving the
GxGxxG motif, remain the same. The remaining loop residues
Leu57, Glu59, and Gly60 are not involved in binding the cofactor.
Conclusions: General Cofactor Binding Principles for KARIs. We iden-
tiﬁed a common motif for cofactor speciﬁcity in KARIs by using
structural knowledge to identify the critical role of the β2αB loop
and deconvolute its three key variations in multiple sequence
alignments, thereby deﬁning a limited set of mutations that gen-
erate NADH speciﬁcity. Applying this to KARIs with different
loop lengths has enabled us to develop a robust guide to switching
the cofactor preference fromNADPH to NADH of any enzyme in
this family. This approach opens the door to exploration of
a wealth of different KARI properties in the context of valuable
BCAA pathways under anaerobic conditions.
Materials and Methods
Cloning and Library Construction. Strains, plasmids, and primers are listed in
Tables S5 and S6. The genes encoding S. exigua Se_KARI, L. lactis Ll_KARI,
Shewanella sp. Sh_KARI, and Sh_KARI6E6 were obtained from DNA2.0. The
genes encoding M. aeolicus Ma_KARI and A. acidocaldarius Aa_KARI were
obtained as gBlocks from Integrated DNA Technologies. For each gene, the
Fig. 4. Crystal structures of Se_KARI wild-type enzyme with cocrystallized NADPH (Left, cyan) and variant Se_KARIDDV with cocrystallized NADH (Right,
green). The β2αB loop is highlighted, and side chains involved in deﬁning cofactor-speciﬁcity are shown as sticks. Introduced mutations (Ser61Asp, Ser63Asp,
and Ile95Val) are shown with red labels. In Se_KARIDDV, Ser61Asp and Ser63Asp compensate for the missing 2′-phosphate and electrostatically and sterically
exclude NADPH. Mutation Ile95Val allows the adenine moiety to shift 1 Å inward. The backbone of Arg58 follows this movement, so that in both structures
the cation–pi interaction with the adenine moiety is preserved.
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gBlocks were assembled via PCR, using T7 promoter and terminator primers
and Phusion polymerase following the manufacturer’s instructions (Thermo
Scientiﬁc). Site-saturation mutagenesis libraries were made by splicing by
overlap extension PCR (30), as described (7). Error-prone PCR was performed
according to a published protocol (31), using commercial T7 promoter and
terminator primers. All KARIs and libraries were cloned into pET22(b)+, using
NdeI and XhoI in frame with the C-terminal his-tag for expression in E. coli.
Heterologous protein expression, high-throughput expression, and puriﬁca-
tion were conducted as described (7).
Kinetic Assays and High-Throughput Screening. For the high-throughput as-
says, E. coli cells were lysed with 100 mM potassium phosphate at pH 7, 750
mg/L lysozyme, and 10 mg/L DNaseI. KARI activities were then assayed by
monitoring NAD(P)H consumption in the presence of S2AL at 340 nm in
a plate reader. The assay buffer contained 100 mM potassium phosphate at
pH 7, 1 mM DTT, 200 μMNAD(P)H, 12.5 mM S2AL for Ll_KARI and 2.5 mM for
the other KARIs, and 10 mM MgCl2. The Ll_KARI error-prone PCR library was
screened at 5 mM S2AL. The Ec_IlvC6E6 library was screened at 1 mM S2AL.
The Se_KARIDD library was screened at 100 μM NADH and 2.5 mM S2AL.
KARI Sequence Alignment. Manually annotated and reviewed sequence data
for ketol-acid reductoisomerases (E.C. 1.1.1.86) were retrieved from the
Uniprot Database (32). Clustal Omega (33, 34) was used to perform a mul-
tiple sequence alignment. The sequence logo plot (35) was created with the
WebLogo 3.3 interface (36).
Crystallization and Data Collection. N-hydroxy-N-isopropyloxamate was pre-
pared as described (37). High-throughput screeningof crystallization conditions
for Se_KARI and Se_KARIDDV was conducted at the Beckman Molecular Ob-
servatory at the California Institute of Technology. For Se_KARI with NADPH,
the best condition was an unbuffered 0.2 M di-ammonium tartrate solution
containing 20% (wt/vol) PEG3350 as precipitant. For Se_KARIDDV with NADH
and N-hydroxy-N-isopropyloxamate as inhibitor, the best condition was an
unbuffered 0.1-M potassium thiocyanate solution with 30% (wt/vol) poly-
ethylene glycolmonomethyl ether 2000as precipitant. The crystals were soaked
in Fomblin oil for cryoprotection before ﬂash-freezing in liquid nitrogen. Dif-
fraction data were collected using a Dectris Pilatus 6M detector on beamline
12–2 at the Stanford Synchrotron Radiation Laboratory at 100 K. Diffraction
datasets were integrated with XDS (38) and scaled using SCALA (39).
Structure Determination and Reﬁnement. For Se_KARI, the structure of Pseu-
domonas aeruginosa KARI [PDB code 1NP3 (24)] was used as for molecular re-
placement. A multiblock reﬁnement was applied dividing the model in six
subparts according to secondary structure elements (residues 1–202, 203–228,
229–252, 253–278, 279–308, and 309–337) to allow automated standard re-
ﬁnement with Phenix (CCP4 suite). Reﬁnement was conducted by iterating
automatic reﬁnement with Refmac5 (CCP4 suite) andmanual reﬁnement using
Coot (40). We used the reﬁned wild-type structure as a model for molecular
replacement to obtain the structure for Se_KARIDDV. After placement of the
inhibitor, several iterations of automated reﬁnement with Refmac5 and man-
ual reﬁnement in Coot were performed. The structures were submitted to the
protein database as PDB 4KQW (Se_KARI) and PDB 4KQX (Se_KARIDDV).
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